| Jangka wektu | Prediksi rega | kepungkur | Sajarah | Wawasan |
|---|---|---|---|---|
| sesuk | $129.18 ▼ -0.80% | wingi | $130.66 ▲ +0.33% | Sesuk Neurocrine Biosciences Inc. Common Stock (NBIX) persiyapan wis anchored kanggo $130.22 lan target $129.18 (-0.80%). Waca sing cedhak yaiku kekurangane; nonton $134.13 / $126.31 amarga volatilitas sing diwujudake saben dina babagan 4.10%. |
Sesuk Neurocrine Biosciences Inc. Common Stock (NBIX) persiyapan wis anchored kanggo $130.22 lan target $129.18 (-0.80%). Waca sing cedhak yaiku kekurangane; nonton $134.13 / $126.31 amarga volatilitas sing diwujudake saben dina babagan 4.10%. | ||||
| Minggu | $127.00 ▼ -2.48% | Minggu kepungkur | $131.57 ▲ +1.04% | Model 7 dina Neurocrine Biosciences Inc. Common Stock pindhah saka $131.57 menyang $127.00 (-2.48%). Iku menehi konteks momentum kekurangane kanggo saham iki, supaya break watara $134.13 / $126.31 prakara luwih saka siji obah. |
Model 7 dina Neurocrine Biosciences Inc. Common Stock pindhah saka $131.57 menyang $127.00 (-2.48%). Iku menehi konteks momentum kekurangane kanggo saham iki, supaya break watara $134.13 / $126.31 prakara luwih saka siji obah. | ||||
| wulan | $123.36 ▼ -5.27% | Wulan kepungkur | $133.10 ▲ +2.21% | Target 1 wulan Neurocrine Biosciences Inc. Common Stock yaiku $123.36 (-5.27%), dibandhingake karo referensi langsung ing cedhak $130.22. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. |
Target 1 wulan Neurocrine Biosciences Inc. Common Stock yaiku $123.36 (-5.27%), dibandhingake karo referensi langsung ing cedhak $130.22. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. | ||||
| taun | $117.90 ▼ -9.46% | Taun kepungkur | $135.40 ▲ +3.97% | Skenario 1 taun Neurocrine Biosciences Inc. Common Stock nuduhake $117.90 (-9.46%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. |
Skenario 1 taun Neurocrine Biosciences Inc. Common Stock nuduhake $117.90 (-9.46%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. | ||||
| 5 Taun | $105.11 ▼ -19.29% | 5 Taun kepungkur | $140.77 ▲ +8.10% | Tampilan 5 taun Neurocrine Biosciences Inc. Common Stock yaiku $105.11 (-19.29%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. |
Tampilan 5 taun Neurocrine Biosciences Inc. Common Stock yaiku $105.11 (-19.29%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. | ||||
| Indikator | Nilai | Sinyal |
|---|---|---|
| regane | $130.22 | agêng |
| Ganti saben dina | -1.04% | Ngisor |
| Volatilitas Kab | 20.0% | agêng |
| kapercayan | 59% | Ngisor |
| Sumber Data | nasdaq-screener | agêng |
| saiki | $130.22 | Ganti saben dina | -1.04% |
| Pasar Kab | $13.10B | Sumber | nasdaq-screener |
Gagasan sing gegandhengan kanggo navigasi internal, diklompokaké miturut persiyapan sisih ndhuwur sing luwih kuwat lan kurang lemah ing pasar sing padha.